INSIGHTS ON LIQUID DOSE MANUFACTURING

• Key Topics And Trends In Aseptic Filling

  Aseptic filling is vital yet often guided by outdated practices. Discover expert insights on modern technologies, evolving regulations, and data-driven strategies to improve compliance and reduce risk in this critical manufacturing step.

• Sterility Testing Of Products To Be Diluted In Isopropyl Myristate

  Discover one possible test set-up to dilute a product in isopropyl myristate, filter it, and rinse the membrane to eliminate residues that may inhibit microbial growth.

• Re-Engineering A Complex Process For FDA Compliance

  Discover the strategies that helped a company navigate a complex and shifting regulatory landscape to rapidly re-engineer a COVID-19 vaccine manufacturing process for FDA compliance.

• Barrel Filling Vs. Tip Filling A Syringe – Which Approach Should Be Used?

  There are two primary filling methods for pre-filled syringes. Explore the pros and cons of each approach, highlighting why barrel filling is generally preferred in the pharmaceutical industry.

• Simplify Cell Line Development

  11/7/2025

  A streamlined workflow combining microfluidic dispensing and multimodal imaging enables efficient single-cell isolation, viability assessment, and outgrowth analysis to support cell line development.

• The Journey Of A CDMO Choosing Pre-Sterilized Drug Containers

  2/4/2025

  Explore innovation in pharmaceutical manufacturing with advanced drug containment, delivery systems, and automation, ensuring quality, safety, and efficiency in injectable therapies for global healthcare.

   

• Ensuring Integrity: Testing Viscous Biologics In Pre-Filled Syringes

  12/18/2025

  Viscous biologics in pre-filled syringes demand precise integrity testing. Discover how advanced HVLD technology detects micro-defects and ensures sterility, meeting stringent USP <1207> standards.

• Fill-Finish Contract Manufacturing: Trends, Challenges, And The Future

  9/16/2025

  See why it's important to partner with a CDMO that’s investing in advanced sterile fill-finish capabilities to meet the demands of complex biologics, gene therapies, and mRNA-based products.

• Simtra Capabilities Update April 2026: Fill/Finish

  4/28/2026

  A look at sterile injectable expansion highlighting investment, advanced fill‑finish technologies, and flexible manufacturing from development to commercial production.